SIRT3 and acute respiratory distress syndrome: Notably, treatment with the Sirt3 inhibitor 3-TYP significantly increased serum inflammatory factor levels in LPS- and CLP-induced ALI models, indicating that Sirt3 was negatively related to lung inflammation.